
About


Advanced IP Considerations for Cell-and-Gene Therapeutic Companies Utilizing Lipid Nanoparticle Delivery Systems

mRNA IP 2022 Year in Review: Pioneers Clash in Major Patent Litigations

The Current mRNA/LNP Patent Litigation Landscape

Merck and Orna Therapeutics Join Forces in Circular RNA Collaboration

Arbutus and Genevant Sue Moderna in First Significant Patent Infringement Lawsuit in the mRNA Space

Delaware Judge Denies Sarepta Protection Under Hatch-Waxman “Safe Harbor”

mRNA Patent and Competitive Landscape: 2021 Year in Review and 2022 Outlook

Three (3) Initial Considerations for Entrepreneurial Faculty, Researchers, Post-Docs, and Graduate Students
